Concepedia

Belén Atienza‐Mateo

BA

Statistics

Publications

41

Citations

1.3K

H-Index

20

Active since

2018

Affiliations

Instituto de Investigación Marqués de Valdecilla(Current)

Marqués de Valdecilla University Hospital

Universidad de Cantabria

University of the Witwatersrand

Hospital Universitario de La Princesa

Belén Atienza‐Mateo is an author at Instituto de Investigación Marqués de Valdecilla specializing in medicine, autoimmunity, and rheumatology.

ORCID

Publications per year

2018–2025

41

Publications

41

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 116 citations · Full text

, , +15

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 110 citations · Full text

, , +9

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Belén Atienza‐Mateo, V. Calvo-Río, E. Beltrán et al. · Lara D. Veeken · 2018 · 107 citations

, , +17

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 88 citations · Full text

, , +14

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán et al. · Ophthalmology · 2018 · 70 citations · Full text

, , +13

1–5 of 41